Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|February 10, 2016
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infectionsAlejandro Ortiz-Covarrubias, Edward Fang, Philippe G Prokocimer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortalityMelinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Medicina|January 25, 2024
Characteristics of endemic human coronavirus infections during times of COVID-19 pandemicEric E Crocci, Delfina Schreiner, Emilia A García, et al.
Emerging Infectious Diseases|December 21, 2020
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020Lucila M Carosella, Daniel Pryluka, Aldo Maranzana, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 2013
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitalsSandra Rincón, Jinnethe Reyes, Lina Paola Carvajal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupYohei Doi, Robert A Bonomo, David C Hooper, et al.
Scandinavian Journal of Infectious Diseases|September 22, 2010
Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, ArgentinaMarcia Querci, Martin E Stryjewski, Fabián Herrera, et al.
Journal of Clinical Microbiology|October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trialIn-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases|June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE studyMartin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
Medicina|October 23, 2023
[Impact of population mobility on the behavior of respiratory viruses during the COVID-19 pandemic]Manuela Cobos, Esteban C Nannini, Juan P Balbuena, et al.
Pageof 10